Hsieh, J. C., Chiang, P., Hung, T., Chao, Y., Kuo, Y., Wen, C., . . . Wang, H. (2021). Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence. Wiley.
Cita Chicago Style (17a ed.)Hsieh, Jason Chia‐Hsun, et al. Definitive Concurrent Chemoradiotherapy with Paclitaxel Plus Carboplatin Is Superior to Cisplatin Plus 5‐fluorouracil in Patients with Inoperable Esophageal Squamous Cell Carcinoma Using Retrospective, Real‐world Evidence. Wiley, 2021.
Cita MLA (8a ed.)Hsieh, Jason Chia‐Hsun, et al. Definitive Concurrent Chemoradiotherapy with Paclitaxel Plus Carboplatin Is Superior to Cisplatin Plus 5‐fluorouracil in Patients with Inoperable Esophageal Squamous Cell Carcinoma Using Retrospective, Real‐world Evidence. Wiley, 2021.